Minerva Neurosciences, Inc. Common Stock, Value, Issued
Minerva Neurosciences, Inc. (NERV) had Common Stock, Value, Issued of $4.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $4.72K.
- 2026-03-31: Common Stock, Value, Issued $4.38K.
- 2025-12-31: Common Stock, Value, Issued $4.33K.
- 2025-09-30: Common Stock, Value, Issued $699.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $4.72K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $4.38K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $4.33K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $699.00 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $699.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $699.00 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $699.00 10-K · filed 2026-03-11 | |
| 2024-09-30 | $699.00 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $699.00 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $699.00 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $699.00 10-K · filed 2025-02-25 | |
| 2023-09-30 | $699.00 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $699.00 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $534.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $534.00 10-K · filed 2024-02-22 | |
| 2022-09-30 | $534.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $534.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $4.27K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $534.00 10-K · filed 2023-03-08 | $4.27K 10-K · filed 2022-03-01 |
| 2021-09-30 | $4.27K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $4.27K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $4.27K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $4.27K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $4.27K 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $4.07K 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $3.92K 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $3.91K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $3.90K 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $3.90K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $3.90K 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $3.89K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $3.88K 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $3.88K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $3.88K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $3.88K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $3.87K 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $3.68K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $3.67K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $3.50K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $3.48K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $3.48K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $2.79K 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $2.47K 10-K · filed 2017-03-13 | |
| 2015-09-30 | $2.47K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.47K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $2.47K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.84K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $1.84K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $852.00 10-Q · filed 2014-08-07 | |
| 2013-12-31 | $611.00 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |